EX-FILING FEES 4 brhc10049904_ex107-1.htm EXHIBIT 107.1
Exhibit 107.1

Calculation of Filing Fee Tables

Form S-8
(Form Type)

Kinnate Biopharma Inc.
(Exact name of registrant as specified in its charter)

Table 1 - Newly Registered Securities
Security
Type
Security Class Title
Fee
Calculation
Rule
Amount
Registered(1)
Proposed
Maximum
Offering
Price Per
Unit
Maximum
Aggregate
Offering Price
Fee Rate
Amount of
Registration
Fee
Equity
Common Stock, $0.0001 par value per share, reserved for issuance pursuant to the 2020 Equity Incentive Plan
Rule 457(c) and Rule 457(h)
2,217,114 (2)
$3.60 (3)
$7,981,610.40
0.0001102
$879.57
Equity
Common Stock, $0.0001 par value per share, reserved for issuance pursuant to the 2020 Employee Stock Purchase Plan
Rule 457(c) and Rule 457(h)
443,422 (4)
$3.06 (5)
$1,356,871.32
0.0001102
$149.53
Total Offering Amounts       $9,338,481.72   $1,029.10
Total Fee Offsets (6)           -
Net Fee Due           $1,029.10


(1)
Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this Registration Statement shall also cover any additional shares of the Registrant’s common stock (“Common Stock”) that become issuable under the 2020 Equity Incentive Plan (the “2020 Plan”) and 2020 Employee Stock Purchase Plan (the “2020 ESPP”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding shares of Common Stock.

(2)
Represents an automatic increase of 5% of the outstanding shares of Common Stock on the last day of the immediately preceding fiscal year to the number of Common Stock reserved for issuance under, and which annual increase is provided for, in the 2020 Plan.

(3)
Estimated in accordance with Rule 457 (c) and (h) solely for the purpose of calculating the registration fee on the basis of $3.60 per share, which is the average of the high and low sale prices of Common Stock as reported on the Nasdaq Global Select Market on March 10, 2023.

(4)
Represents an automatic increase of 1% of the outstanding shares of Common Stock on the last day of the immediately preceding fiscal year to the number of Common Stock reserved for issuance under, and which annual increase is provided for, in the 2020 ESPP.

(5)
Estimated in accordance with Rule 457 (c) and (h) solely for the purpose of calculating the registration fee on the basis of 85% of $3.60 per share, which is the average of the high and low sale prices of Common Stock as reported on the Nasdaq Global Select Market on March 10, 2023. Pursuant to the 2020 ESPP, the purchase price of Common Stock reserved for issuance thereunder will be at least 85% of the lower of the fair market value of Common Stock on the Enrollment Date or the Exercise Date (as such terms are defined in the 2020 ESPP).

(6)
The Registrant does not have any fee offsets.